196 related articles for article (PubMed ID: 30410330)
1. Effect of CCR2 inhibitor-loaded lipid micelles on inflammatory cell migration and cardiac function after myocardial infarction.
Wang J; Seo MJ; Deci MB; Weil BR; Canty JM; Nguyen J
Int J Nanomedicine; 2018; 13():6441-6451. PubMed ID: 30410330
[TBL] [Abstract][Full Text] [Related]
2. Ly6C
Schloss MJ; Hilby M; Nitz K; Guillamat Prats R; Ferraro B; Leoni G; Soehnlein O; Kessler T; He W; Luckow B; Horckmans M; Weber C; Duchene J; Steffens S
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1640-1645. PubMed ID: 28663258
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.
Majmudar MD; Keliher EJ; Heidt T; Leuschner F; Truelove J; Sena BF; Gorbatov R; Iwamoto Y; Dutta P; Wojtkiewicz G; Courties G; Sebas M; Borodovsky A; Fitzgerald K; Nolte MW; Dickneite G; Chen JW; Anderson DG; Swirski FK; Weissleder R; Nahrendorf M
Circulation; 2013 May; 127(20):2038-46. PubMed ID: 23616627
[TBL] [Abstract][Full Text] [Related]
4. Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.
Bajpai G; Bredemeyer A; Li W; Zaitsev K; Koenig AL; Lokshina I; Mohan J; Ivey B; Hsiao HM; Weinheimer C; Kovacs A; Epelman S; Artyomov M; Kreisel D; Lavine KJ
Circ Res; 2019 Jan; 124(2):263-278. PubMed ID: 30582448
[TBL] [Abstract][Full Text] [Related]
5. Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.
Lu W; Xie Z; Tang Y; Bai L; Yao Y; Fu C; Ma G
Theranostics; 2015; 5(10):1068-82. PubMed ID: 26199646
[TBL] [Abstract][Full Text] [Related]
6. Monocytes prime autoreactive T cells after myocardial infarction.
DeBerge M; Yu S; Dehn S; Ifergan I; Yeap XY; Filipp M; Becker A; Luo X; Miller S; Thorp EB
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H116-H123. PubMed ID: 31809213
[TBL] [Abstract][Full Text] [Related]
7. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery.
Elsaid Z; Taylor KM; Puri S; Eberlein CA; Al-Jamal K; Bai J; Klippstein R; Wang JT; Forbes B; Chana J; Somavarapu S
Eur J Pharm Sci; 2017 Apr; 101():228-242. PubMed ID: 28163163
[TBL] [Abstract][Full Text] [Related]
8. The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.
Cochain C; Auvynet C; Poupel L; Vilar J; Dumeau E; Richart A; Récalde A; Zouggari Y; Yin KY; Bruneval P; Renault G; Marchiol C; Bonnin P; Lévy B; Bonecchi R; Locati M; Combadière C; Silvestre JS
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2206-13. PubMed ID: 22796582
[TBL] [Abstract][Full Text] [Related]
9. S100A9 Links Inflammation and Repair in Myocardial Infarction.
Marinković G; Koenis DS; de Camp L; Jablonowski R; Graber N; de Waard V; de Vries CJ; Goncalves I; Nilsson J; Jovinge S; Schiopu A
Circ Res; 2020 Aug; 127(5):664-676. PubMed ID: 32434457
[TBL] [Abstract][Full Text] [Related]
10. β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.
Grisanti LA; Traynham CJ; Repas AA; Gao E; Koch WJ; Tilley DG
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15126-15131. PubMed ID: 27956622
[TBL] [Abstract][Full Text] [Related]
11. Topiramate modulates post-infarction inflammation primarily by targeting monocytes or macrophages.
Wang Z; Huang S; Sheng Y; Peng X; Liu H; Jin N; Cai J; Shu Y; Li T; Li P; Fan C; Hu X; Zhang W; Long R; You Y; Huang C; Song Y; Xiang C; Wang J; Yang Y; Liu K
Cardiovasc Res; 2017 Apr; 113(5):475-487. PubMed ID: 28339742
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery.
Wu H; Zhu L; Torchilin VP
Biomaterials; 2013 Jan; 34(4):1213-22. PubMed ID: 23102622
[TBL] [Abstract][Full Text] [Related]
13. Carbon Monoxide Impairs CD11b
Wu J; Zhang R; Hu G; Zhu HH; Gao WQ; Xue J
J Immunol; 2018 Mar; 200(6):2104-2114. PubMed ID: 29440506
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase induces monocyte migration and activation after acute myocardial infarction.
Peters VBM; Matheis F; Erdmann I; Nemade HN; Muders D; Toubartz M; Torun M; Mehrkens D; Geißen S; Nettersheim FS; Picard F; Guthoff H; Hof A; Arkenberg P; Arand B; Klinke A; Rudolph V; Hansen HP; Bachurski D; Adam M; Hoyer FF; Winkels H; Baldus S; Mollenhauer M
Front Immunol; 2024; 15():1360700. PubMed ID: 38736886
[TBL] [Abstract][Full Text] [Related]
15. Gas6 Promotes Inflammatory (CCR2
Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
17. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
[TBL] [Abstract][Full Text] [Related]
18. Splenic Ly6C
Tomczyk M; Kraszewska I; Szade K; Bukowska-Strakova K; Meloni M; Jozkowicz A; Dulak J; Jazwa A
Basic Res Cardiol; 2017 Jul; 112(4):39. PubMed ID: 28534119
[TBL] [Abstract][Full Text] [Related]
19. Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling.
Dong F; Khalil M; Kiedrowski M; O'Connor C; Petrovic E; Zhou X; Penn MS
Circ Res; 2010 Feb; 106(3):601-10. PubMed ID: 20035082
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.
Ashok B; Arleth L; Hjelm RP; Rubinstein I; Onyüksel H
J Pharm Sci; 2004 Oct; 93(10):2476-87. PubMed ID: 15349957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
